Clinical trial
Mycophenolate Mofetil in Systemic Sclerosis
NCT00433186 · Boston University, Other · Completed
Key facts
| NCT number | NCT00433186 |
|---|---|
| Title | Mycophenolate Mofetil in Systemic Sclerosis |
| Official title | Phase I, Open-label Study of Mycophenolate Mofetil In Systemic Sclerosis |
| Lead sponsor | Boston University, Other |
| Collaborators | Aspreva Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diffuse Cutaneous Systemic Sclerosis |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Feb 9, 2007 |
| Last update posted | Mar 31, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: